Results 21 to 30 of about 210,500 (260)

Low Sputum Smear Positive Tuberculosis among Pulmonary Tuberculosis Suspects in a Tertiary Hospital in Mwanza, Tanzania [PDF]

open access: yes, 2012
Early diagnosis of tuberculosis (TB) and prompt initiation of treatment are essential for an effective tuberculosis control programme. In many resource limited settings microscopic diagnosis is still the pivotal tool in the diagnosis of pulmonary TB ...
Kidenya , Benson R.   +14 more
core   +1 more source

Losses along the tuberculosis sputum sample referral cascade for Mpongwe District, Zambia

open access: yesAfrican Journal of Primary Health Care & Family Medicine, 2023
Background: In resource limited-settings, timely tuberculosis (TB) diagnosis depends upon referral of sputum samples from non-diagnostic to diagnostic facilities for examination.
Lyson Nkhoma   +7 more
doaj   +1 more source

Detection of Mycobacterium tuberculosis in sputum by gas chromatography-mass spectrometry of methyl mycocerosates released by thermochemolysis. [PDF]

open access: yes, 2012
Tuberculosis requires rapid diagnosis to prevent further transmission and allow prompt administration of treatment. Current methods for diagnosing pulmonary tuberculosis lack sensitivity are expensive or are extremely slow.
Minnikin, David E   +36 more
core   +1 more source

Detection of Bacteriophage Particles Containing Antibiotic Resistance Genes in the Sputum of Cystic Fibrosis Patients

open access: yesFrontiers in Microbiology, 2018
Cystic fibrosis (CF) is a chronic disease in which the bacterial colonization of the lung is linked to an excessive inflammatory response that leads to respiratory failure. The microbiology of CF is complex.
Maryury Brown-Jaque   +10 more
doaj   +1 more source

Development of sample clean up methods for the analysis of Mycobacterium tuberculosis methyl mycocerosate biomarkers in sputum extracts by gas chromatography-mass spectrometry. [PDF]

open access: yes, 2015
A proof of principle gas chromatography-mass spectrometry method is presented, in combination with clean up assays, aiming to improve the analysis of methyl mycocerosate tuberculosis biomarkers from sputum.
O'Sullivan, Denise M.   +17 more
core   +1 more source

Performance of Molecular Approaches for Aspergillus Detection and Azole Resistance Surveillance in Cystic Fibrosis

open access: yesFrontiers in Microbiology, 2018
Aspergillus fumigatus triazole resistance is an emerging concern for treating chronically infected/colonized patients. This study sought to evaluate the performance of PCR assays to detect Aspergillus fungi together with azole resistance in sputum ...
Hélène Guegan   +7 more
doaj   +1 more source

Prevalence of pulmonary tuberculosis in post-coronavirus disease patients

open access: yesEgyptian Journal of Chest Disease and Tuberculosis, 2023
Context Post-coronavirus disease 2019 (COVID-19) disease patients are immunocompromised, especially those who have a history of hospitalization during the COVID time and steroid use during hospitalization.
Sandeep Nain   +5 more
doaj   +1 more source

Recent Insights into the Management of Inflammation in Asthma [Letter]

open access: yesJournal of Inflammation Research, 2021
Aleksandr Urakov,1,2,* Natalya Urakova1,* 1Department of General and Clinical Pharmacology, Izhevsk State Medical Academy, Izhevsk City, Udmurt Republic, Russian Federation; 2Institute of Applied Mechanics, Udmurt Federal Research Center of the Ural ...
Urakov A, Urakova N
doaj  

Pathogenetic Reasoning of Administration of Mucolytic Agents for Respiratory Diseases in Children

open access: yesZdorovʹe Rebenka, 2015
The paper presents the mechanisms of cough and bronchial obstruction in lesions of the respiratory tract of various origins. The effect of microbial biofilms on the course of diseases was considered particularly. The methods to restore bronchial drainage
Ye.I. Yulish
doaj   +1 more source

Sputum biomarkers and the prediction of clinical outcomes in patients with cystic fibrosis. [PDF]

open access: yes, 2012
Lung function, acute pulmonary exacerbations (APE), and weight are the best clinical predictors of survival in cystic fibrosis (CF); however, underlying mechanisms are incompletely understood.
Rogers, S.L.   +84 more
core   +2 more sources

Home - About - Disclaimer - Privacy